Krishna Institute of Medical Sciences Ltd
NSE:KIMS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Krishna Institute of Medical Sciences Ltd
PP&E Net
Krishna Institute of Medical Sciences Ltd
PP&E Net Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Krishna Institute of Medical Sciences Ltd
NSE:KIMS
|
PP&E Net
₹41.6B
|
CAGR 3-Years
66%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
PP&E Net
₹105.9B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
12%
|
|
|
F
|
Fortis Healthcare Ltd
NSE:FORTIS
|
PP&E Net
₹69.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
6%
|
CAGR 10-Years
14%
|
|
|
Max Healthcare Institute Ltd
NSE:MAXHEALTH
|
PP&E Net
₹70.2B
|
CAGR 3-Years
50%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
|
Narayana Hrudayalaya Ltd
NSE:NH
|
PP&E Net
₹42.9B
|
CAGR 3-Years
27%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
G
|
Global Health Ltd
NSE:MEDANTA
|
PP&E Net
₹30.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Krishna Institute of Medical Sciences Ltd
Glance View
Krishna Institute of Medical Sciences Ltd. (KIMS) has steadily carved out a significant presence in the Indian healthcare sector, rooted in the ethos of delivering accessible and high-quality care. Emerging from its base in Hyderabad, the institution has expanded its reach through a network of multispecialty hospitals spread across several states in southern and western India. KIMS has built its reputation on providing a broad spectrum of healthcare services, ranging from basic preventive care to advanced super specialty treatments. By blending cutting-edge medical technology with a team of experienced professionals, it has positioned itself as a destination for both domestic and international patients seeking reliable medical solutions. The financial engine of KIMS runs on its comprehensive service offerings, which cater to a wide range of medical needs. Revenue streams are generated primarily through inpatient and outpatient services, surgical procedures, diagnostic services, and pharmacy sales. By maintaining a focus on operational efficiency and leveraging economies of scale, KIMS has managed to offer competitive pricing, thus broadening its accessibility. Furthermore, the institution has strategically enhanced its profitability through partnerships, expansions, and an emphasis on sustainability within its operations. This approach not only strengthens its market position but also fuels its capability to reinvest in infrastructure, research, and development, aiming for continuous growth and innovation in the healthcare landscape.
See Also
What is Krishna Institute of Medical Sciences Ltd's PP&E Net?
PP&E Net
41.6B
INR
Based on the financial report for Mar 31, 2025, Krishna Institute of Medical Sciences Ltd's PP&E Net amounts to 41.6B INR.
What is Krishna Institute of Medical Sciences Ltd's PP&E Net growth rate?
PP&E Net CAGR 5Y
39%
Over the last year, the PP&E Net growth was 56%. The average annual PP&E Net growth rates for Krishna Institute of Medical Sciences Ltd have been 66% over the past three years , 39% over the past five years .